Sales & Marketing News | pharmaphorum

News

Mirati challenges Amgen with FDA okay for KRAS drug

Amgen has its first direct competition in the KRAS inhibitor class following FDA approval of Mirati's adagrasib as Krazati for a form of lung cancer.

News

GSK to move HQ to central London, as Canary Wharf plans file...

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosc

News

Roche's head of pharma Bill Anderson heads for exit

Roche announced this morning that its head of pharmaceuticals, Bill Anderson, is leaving the company to pursue "other opportunities" after four years in the role.

News

Amgen agrees $26bn for Horizon following Sanofi withdrawal

In a fresh update, Bloomberg has reported that US biotech Amg

Views & Analysis

An inside peek into pharma marketing at PM Society learning ...

The PM Society’s ‘Is Pharma Marketing built on Straw, Sticks, or Bricks?’ interactive information afternoon, held at The Royal Society of Medicine in London on Tuesday 6th December, set out

News

Ex-Theranos exec Sunny Balwani gets 13 years for fraud

Ramesh “Sunny” Balwani, the former business partner of Theranos founder Elizabeth Holmes, has been sentenced to nearly 13 years in prison after being convicted of wire fraud.

Mirati challenges Amgen with FDA okay for KRAS drug

GSK to move HQ to central London, as Canary Wharf plans file...

Roche's head of pharma Bill Anderson heads for exit

Amgen agrees $26bn for Horizon following Sanofi withdrawal

An inside peek into pharma marketing at PM Society learning ...

Ex-Theranos exec Sunny Balwani gets 13 years for fraud

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks